Can Snowflake’s Premium Valuation Survive a Shifting Cloud Landscape?

Photo of Alex Sirois
By Alex Sirois Published
Can Snowflake’s Premium Valuation Survive a Shifting Cloud Landscape?

© deldevries / Flickr

At $177.49, Snowflake (NYSE:SNOW | SNOW Price Prediction) sits in a wait-and-see zone for investors. The data cloud leader delivered its strongest quarter ever, yet shares remain well below late-2025 highs, leaving investors to decide whether the AI narrative justifies the premium valuation.

Snowflake operates a consumption-based cloud data platform across AWS, Azure, and Google Cloud, positioning itself as the control plane for enterprise AI agents through products like Cortex AI, Cortex Code, and Snowflake Intelligence. After peaking near $280.67 within the past year, the stock has been re-rated lower on competitive worries and software multiple compression, despite business reacceleration.

Why the AI Reacceleration Story Has Teeth

Q1 FY27 was a statement quarter. Product revenue hit $1.33 billion, up 34% year over year, with growth accelerating across the last three quarters from 28.8% to 30.1% to 33.5%. Net revenue retention held at 126%, and remaining performance obligations grew 38% to $9.21 billion, signaling durable backlog.

Management raised full-year FY27 product revenue guidance to $5.84 billion from $5.66 billion and lifted the non-GAAP operating margin target to 13.5%. Catalysts include a $6 billion multi-year AWS agreement, deepened OpenAI partnership, and 13,600+ accounts already using Snowflake AI capabilities. 45 of 51 analysts rating shares Buy or Strong Buy.

Why the Valuation Still Looks Stretched

Snowflake remains unprofitable on GAAP, posting a $326 million operating loss and $295 million net loss this quarter from heavy stock-based compensation. Shares trade at 13.1x sales, 32x book, and a 99x forward earnings multiple, leaving zero margin for execution slips.

Hyperscalers and Databricks push aggressively into the same AI/data workloads. The consumption model cuts both ways: customers can dial usage down during budget rationalization. Pending class action lawsuits from the 2024 disclosure controversy and $2.3 billion in convertible notes add overhangs.

Why Patience Beats Conviction Here

The bull and bear cases roughly cancel. Growth is reaccelerating and AI adoption is real, but the stock already discounts substantial success, and Reddit sentiment scored a bearish 35 on the earnings report despite the beat. A clean path to GAAP profitability, dilution control, and sustained 30%+ product growth would strengthen the bull case. A consumption slowdown or share loss to Databricks would strengthen the bear case.

What the Numbers Actually Say

Shares currently sit at $177.49 against a consensus analyst target of $229.14, implying roughly 29% upside. The ratings breakdown skews bullish:

  • Strong Buy: 10
  • Buy: 35
  • Hold: 6
  • Sell: 0

Year-to-date, SNOW is down 20.1% while the S&P 500 is up 10.05%. Over one year, SNOW is off 15.07% against an S&P 500 gain of 26.95%.

The Verdict: Wait for Margins to Catch Up to the Multiple

At $177.49, Snowflake looks fairly valued on current fundamentals. The business is too healthy to short, with $232.8 million of quarterly free cash flow, accelerating product revenue, and a credible AI roadmap. Yet 13x sales and a forward multiple near 99 require operating margins to expand meaningfully before the next leg higher becomes durable.

The upgrade trigger is visibility on GAAP profitability and moderating dilution from roughly $423 million quarterly stock-based comp. A downgrade trigger is sequential growth deceleration back toward the high 20s, especially if NRR slips below 120%. Watch Q2 FY27 product revenue against the $1.415 billion to $1.420 billion guide and Cortex monetization disclosures.

The cost of patience is modest given the stock’s history of round-tripping; the cost of acting prematurely at this multiple is far steeper. Snowflake earns its premium through margin expansion, not narrative, and that proof takes several quarters.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

MRNA Vol: 12,438,644
GEV Vol: 3,992,077
WDC Vol: 13,520,513
AMAT Vol: 11,030,053
AVGO Vol: 39,967,336

Top Losing Stocks

KMX Vol: 9,633,759
CTRA Vol: 73,319,495
EFX Vol: 2,027,364
CHTR Vol: 3,520,573
NDAQ Vol: 8,563,198